巨细胞动脉炎的预后
Prognosis in giant-cell arteritis.
作者信息
Graham E, Holland A, Avery A, Russell R W
出版信息
Br Med J (Clin Res Ed). 1981 Jan 24;282(6260):269-71. doi: 10.1136/bmj.282.6260.269.
Abstract
In a study to assess the natural history of giant-cell arteritis, 90 patients with proved disease were followed up from the time of diagnosis. Early mortality was low and most commonly due to vertebral arteritis, but cerebral infarction did not appear to be a late complication. High maintenance dose steroids and visual loss were associated significantly with a shortened life span (p=0.0003 and p=0.0024). One-third of the patients developed chronic relapsing disease, but serious late complications were not encountered. After the initial attack has been controlled steroid dosage should be reduced to the minimum needed to alleviate symptoms.
摘要
在一项评估巨细胞动脉炎自然病程的研究中，90例确诊患者从诊断时开始接受随访。早期死亡率较低，最常见的原因是椎动脉炎，但脑梗死似乎不是晚期并发症。高维持剂量的类固醇和视力丧失与寿命缩短显著相关（p = 0.0003和p = 0.0024）。三分之一的患者发展为慢性复发性疾病，但未出现严重的晚期并发症。在初始发作得到控制后，应将类固醇剂量减至缓解症状所需的最低水平。
相似文献
1
Prognosis in giant-cell arteritis.
Br Med J (Clin Res Ed). 1981 Jan 24;282(6260):269-71. doi: 10.1136/bmj.282.6260.269.
2
Survival in temporal arteritis.
Trans Ophthalmol Soc U K (1962). 1980 Apr;100(Pt 1):108-10.
3
[On neurological complications of giant cell arteritis (so-called temporal arteritis)].
Munch Med Wochenschr. 1969 May 16;111(20):1141-4.
4
Giant cell arteritis.
Curr Opin Ophthalmol. 2007 Nov;18(6):443-9. doi: 10.1097/ICU.0b013e3282f0b4a9.
5
Temporal arteritis. Aggressive treatment prevents visual complications.
Postgrad Med. 1992 May 1;91(6):337-8, 341-2. doi: 10.1080/00325481.1992.11701333.
6
Giant cell arteritis.
Neurol Clin. 2010 Aug;28(3):581-91. doi: 10.1016/j.ncl.2010.03.002. Epub 2010 May 15.
7
[Polymyalgia rheumatica and giant cell arteritis].
Z Rheumaforsch. 1971 Nov-Dec;30(11):324-9.
8
Temporal arteritis. General review with emphasis on atypical manifestations and cardiovascular complications.
Cardiol Clin. 1991 Aug;9(3):547-53.
9
Update on giant cell arteritis.
Curr Opin Ophthalmol. 2003 Dec;14(6):332-8. doi: 10.1097/00055735-200312000-00003.
10
Risk factors for early visual deterioration in temporal arteritis.
J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1255-9. doi: 10.1136/jnnp.2006.113787. Epub 2007 May 15.
引用本文的文献
1
Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry.
Arthritis Res Ther. 2025 Jan 7;27(1):4. doi: 10.1186/s13075-024-03468-6.
2
Giant-cell arteritis related strokes: scoping review of mechanisms and rethinking treatment strategy?
Front Neurol. 2023 Dec 7;14:1305093. doi: 10.3389/fneur.2023.1305093. eCollection 2023.
3
Measuring treatment outcomes and change in disease activity in giant cell arteritis: a systematic literature review informing the development of the EULAR-ACR response criteria on behalf of the EULAR-ACR response criteria in giant cell arteritis task force.
RMD Open. 2023 Jun;9(2). doi: 10.1136/rmdopen-2023-003233.
4
Frequency of visual involvement in a 10-year interdisciplinary cohort of patients with giant cell arteritis.
Clin Med (Lond). 2023 May;23(3):206-212. doi: 10.7861/clinmed.2022-0415. Epub 2023 May 17.
5
Population-based Rate and Patterns of Diplopia in Giant Cell Arteritis.
Neuroophthalmology. 2021 Aug 20;46(2):75-79. doi: 10.1080/01658107.2021.1965627. eCollection 2022.
6
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis.
RMD Open. 2019 Sep 16;5(2):e001003. doi: 10.1136/rmdopen-2019-001003. eCollection 2019.
7
Arteritic Anterior Ischemic Optic Neuropathy Associated with Giant-Cell Arteritis in Korean Patients: A Retrospective Single-Center Analysis and Review of the Literature.
J Clin Neurol. 2019 Jul;15(3):386-392. doi: 10.3988/jcn.2019.15.3.386.
8
Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Arthritis Res Ther. 2019 Jun 25;21(1):154. doi: 10.1186/s13075-019-1945-4.
9
Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis.
Ophthalmology. 2016 Sep;123(9):1999-2003. doi: 10.1016/j.ophtha.2016.05.008. Epub 2016 Jun 11.
10
Flares in Biopsy-Proven Giant Cell Arteritis in Northern Italy: Characteristics and Predictors in a Long-Term Follow-Up Study.
Medicine (Baltimore). 2016 May;95(19):e3524. doi: 10.1097/MD.0000000000003524.
本文引用的文献
1
Giant-Cell or Temporal Arteritis: a Review.
J Clin Pathol. 1948 Aug;1(4):197-211.
2
The visual changes in temporal (giant-cell) arteritis. Report of a case with autopsy findings.
Brain. 1959 Sep;82:377-90. doi: 10.1093/brain/82.3.377.
3
Ocular palsy in temporal arteritis. I.
Minn Med. 1959 Sep;42:1258-68; contd.
4
Sudden blindness in cranial arteritis.
Br J Ophthalmol. 1959 Apr;43(4):204-16. doi: 10.1136/bjo.43.4.204.
5
Computing man years at risk.
Br J Prev Soc Med. 1972 May;26(2):132-4. doi: 10.1136/jech.26.2.132.
6
Ophthalmoplegia in cranial arteritis.
Brain. 1977 Jun;100(2):209-21. doi: 10.1093/brain/100.2.209.
7
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.
Br J Cancer. 1977 Jan;35(1):1-39. doi: 10.1038/bjc.1977.1.
8
Visual system involvement in giant cell (temporal) arteritis.
Surv Ophthalmol. 1979 Jan-Feb;23(4):264-71. doi: 10.1016/0039-6257(79)90051-1.
Zotero 插件